Evasion of COPD in smokers: at what price?

被引:22
|
作者
Cosio, Manuel G. [2 ,3 ]
Saetta, Marina [1 ]
机构
[1] Univ Padua, Clin Pneumol, Dept Cardiac Thorac & Vasc Sci, Sect Resp Dis, I-35128 Padua, Italy
[2] McGill Univ, Royal Victoria Hosp, Dept Med, Div Resp, Montreal, PQ H3A 1A1, Canada
[3] McGill Univ, Royal Victoria Hosp, Dept Med, Meakins Christie Labs, Montreal, PQ H3A 1A1, Canada
关键词
Cancer; chronic obstructive pulmonary disease; immune response; monocyte/macrophage; T-LYMPHOCYTE RESPONSE; CIGARETTE-SMOKE; SUPPRESSOR-CELLS; LUNG-CANCER; INFLAMMATION; AIRWAYS; MECHANISMS; EXPRESSION; MALIGNANCY; RESOLUTION;
D O I
10.1183/09031936.00135711
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Investigations toward the understanding of chronic obstructive pulmonary disease (COPD) have been directed, so far, to the study of mechanisms leading to the disease. We believe that understanding why similar to 80% of smokers evade COPD and how this evasion is accomplished might be a fruitful endeavour that could advance knowledge of the development of the disease. Since the inflammatory infiltrate smokers develop seems to be the key element leading to the lung destruction in COPD, the understanding of the possible ways inflammation can be dampened, as well as its consequences, ought to be important. We review here some of the mechanisms by which inflammation is controlled: by the post-translational regulons, by the mechanisms preventing full activation of dendritic cells and by the regulatory T-cells. The potential role of the M2 alveolar macrophage phenotype and the newly described myeloid-derived suppressor cells is mentioned. We also point out that evasion comes at a price, as healthy smokers might be immunosuppressed to some extent and unable to prevent the development of cancer, certainly less so than in severe COPD, where immunity is heightened. Probably, the knowledge of the mechanisms of evasion from COPD could add significantly to the understanding of those leading to the disease.
引用
收藏
页码:1298 / 1303
页数:6
相关论文
共 50 条
  • [21] NEUROPEPTIDE EXPRESSION IN THE AIRWAYS OF COPD PATIENTS AND SMOKERS WITH NORMAL LUNG FUNCTION
    Vatrella, A.
    Montagnani, S.
    Calabrese, C.
    Parrella, R.
    Pelaia, G.
    Biscione, G. L.
    Corcione, N.
    Marsico, S. A.
    Guerra, G.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2010, 24 (04) : 425 - 432
  • [22] Decreased FOXP3 expression in small airways of smokers with COPD
    Isajevs, S.
    Taivans, I.
    Strazda, G.
    Kopeika, U.
    Bukovskis, M.
    Gordjusina, V.
    Kratovska, A.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (01) : 61 - 67
  • [23] Cigarette smoke induces overexpression of active human cathepsin S in lungs from current smokers with or without COPD
    Andrault, Pierre-Marie
    Schamberger, Andrea C.
    Chazeirat, Thibault
    Sizaret, Damien
    Renault, Justine
    Staab-Weijnitz, Claudia A.
    Hennen, Elisabeth
    Petit-Courty, Agnes
    Wartenberg, Mylene
    Saidi, Ahlame
    Baranek, Thomas
    Guyetant, Serge
    Courty, Yves
    Eickelberg, Oliver
    Lalmanach, Gilles
    Lecaille, Fabien
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2019, 317 (05) : L625 - L638
  • [24] MD2 expression is reduced in large airways of smokers and COPD smokers
    Pace, Elisabetta
    Ferraro, Maria
    Chiappara, Giuseppina
    Vitulo, Patrizio
    Pipitone, Loredana
    Di Vincenzo, Serena
    Gjomarkaj, Mark
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2015, 407 (1-2) : 289 - 297
  • [25] MD2 expression is reduced in large airways of smokers and COPD smokers
    Elisabetta Pace
    Maria Ferraro
    Giuseppina Chiappara
    Patrizio Vitulo
    Loredana Pipitone
    Serena Di Vincenzo
    Mark Gjomarkaj
    Molecular and Cellular Biochemistry, 2015, 407 : 289 - 297
  • [26] Reduced Attention in Former Smokers with and without COPD
    Croghan, Anna
    Brunette, Amanda
    Holm, Kristen E.
    Kozora, Elizabeth
    Moser, David J.
    Wamboldt, Frederick S.
    Meschede, Kimberly
    Make, Barry J.
    Crapo, James D.
    Weinberger, Howard D.
    Moreau, Kerrie L.
    Bowler, Russell P.
    Hoth, Karin F.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2019, 26 (06) : 600 - 607
  • [27] COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients
    Alberca, Ricardo Wesley
    Lima, Julia Cataldo
    de Oliveira, Emily Araujo
    Gozzi-Silva, Sarah Cristina
    Leuzzi Ramos, Yasmim Alefe
    de Souza Andrade, Milena Mary
    Beserra, Danielle Rosa
    Oliveira, Luana de Mendonca
    Calvielli Castelo Branco, Anna Claudia
    Pietrobon, Anna Julia
    Pereira, Natalli Zanete
    Emidio Teixeira, Franciane Mouradian
    Fernandes, Iara Grigoletto
    da Silva Duarte, Alberto Jose
    Benard, Gil
    Sato, Maria Notomi
    FRONTIERS IN PHYSIOLOGY, 2021, 11
  • [28] Effect of exercise challenge on systemic inflammatory markers in healthy smokers and smokers with COPD
    Holz, Olaf
    Roepcke, Stefan
    Watz, Henrik
    Lahu, Gezim
    Hohlfeld, Jens M.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [29] Reduced Attention in Former Smokers with and without COPD
    Anna Croghan
    Amanda Brunette
    Kristen E. Holm
    Elizabeth Kozora
    David J. Moser
    Frederick S. Wamboldt
    Kimberly Meschede
    Barry J. Make
    James D. Crapo
    Howard D. Weinberger
    Kerrie L. Moreau
    Russell P. Bowler
    Karin F. Hoth
    International Journal of Behavioral Medicine, 2019, 26 : 600 - 607
  • [30] Systemic inflammatory profile of smokers with and without COPD
    Mosrane, Y.
    Bougrida, M.
    Alloui, A. S.
    Martani, M.
    Rouabah, L.
    Bourahli, M. K.
    Mehdioui, H.
    Ben Saad, H.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2017, 73 (04) : 188 - 198